
“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
Justin Amash: Obama 'Highly Misleading' In Claiming No Domestic Spying Program
U.S. swaps watchdog considering bitcoin regulation
Millions spent to begin razing of 7,000 abandoned properties in Dayton
Carlsbad radar device part of smuggling crackdown
Anger over East German medical ‘human guinea pigs’
Millions affected after cyber attack on HSBC
District Heights officer indicted in shooting of handcuffed man
Feds Offering $48/hr To Obamacare ‘Navigators’ Who Can Actually Explain Obamacare
SWAT teams claim they’re private and immune from open records
Elmore City Police Chief Says He Was Fired Over 'Ticket Quota'
Saudi rights activists given heavy jail terms
Venezuelans blocked from taking flights out by capital controls
Michael Douglas slams U.S. prison system after Emmy win
New U.S. Sanctions Imposed on Iran to Halt Gold Trading
United Nations report: ‘Designer drug’ use, abuse and production surging